Cargando…
SARS-CoV-2 challenge studies: ethics and risk minimisation
COVID-19 poses an exceptional threat to global public health and well-being. Recognition of the need to develop effective vaccines at unprecedented speed has led to calls to accelerate research pathways ethically, including by conducting challenge studies (also known as controlled human infection st...
Autores principales: | Bull, Susan, Jamrozik, Euzebiusz, Binik, Ariella, Parker, Michael J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520819/ https://www.ncbi.nlm.nih.gov/pubmed/32978304 http://dx.doi.org/10.1136/medethics-2020-106504 |
Ejemplares similares
-
Ethics of instantaneous contact tracing using mobile phone apps in the control of the COVID-19 pandemic
por: Parker, Michael J, et al.
Publicado: (2020) -
‘Your country needs you’: the ethics of allocating staff to high-risk clinical roles in the management of patients with COVID-19
por: Dunn, Michael, et al.
Publicado: (2020) -
Ethical analysis examining the prioritisation of living donor transplantation in times of healthcare rationing
por: Kulkarni, Sanjay, et al.
Publicado: (2023) -
Animal researchers shoulder a psychological burden that animal ethics committees ought to address
por: King, Mike, et al.
Publicado: (2022) -
Vaccine-enhanced disease: case studies and ethical implications for research and public health
por: Jamrozik, Euzebiusz, et al.
Publicado: (2021)